Coherus Oncology
A QC Analyst in a biologics laboratory supporting routine testing, method validation, and investigation management. The role involves applying analytical techniques, ensuring compliance with regulatory standards, and leading lab investigations.
Headquarters
Redwood City, California, United States
Company Size
201-500 employees
Founded
2010
Coherus Oncology is a commercial-stage biopharmaceutical company focused on developing next‑generation combination therapies to improve outcomes for people living with cancer. The company advances novel combination regimens through clinical development and commercialization to address unmet needs across oncology. Coherus emphasizes scientific expertise, clinical rigor, and strategic partnerships to bring new therapeutic options to patients.
Coherus Oncology Pivots to Immuno-Oncology, Touts LOQTORZI Growth and New Pipeline at Citizens Conf.
2 days ago
Coherus Oncology: Q4 Earnings Snapshot
1 week ago
Coherus Oncology, Inc. to Release 2025 Financial Results on March 9, 2026, with Conference Call to Follow
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Coherus Oncology.
7% below the average for this role
Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock
4 weeks ago